Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2012BloodOpen Access

Prognostic irrelevance of ring sideroblast percentage in World Health Organization–defined myelodysplastic syndromes without excess blasts

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMrinal M. PatnaikCHCurtis A. HansonNSNanna Sulai

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Patnaik et al. (2012) studied this question.

synapsesocial.com/papers/6a109766e1a472cb5efd2ebahttps://doi.org/10.1182/blood-2012-03-415356
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype2006 · 210 citations
  2. 2MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients2006 · 1,060 citations
  3. 3IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis2010 · 317 citations
  4. 4Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.1992 · 163 citations
  5. 5The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts2008 · 133 citations